IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3016% above fair value
$257.60−7.13 (-2.69%)
Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –
Iqvia ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Iqvia's ebitda for the twelve months ending Sep 30, 2026 was $3.44B, up 3.8% year over year. For fiscal 2025 it was $3.33B, up 0.3% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $3.33B in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.33B | +0.3% |
| FY2024 | Dec 31, 2024 | $3.32B | +6.9% |
| FY2023 | Dec 31, 2023 | $3.10B | +5.9% |
| FY2022 | Dec 31, 2022 | $2.93B | +10.2% |
| FY2021 | Dec 31, 2021 | $2.66B | +31.7% |
| FY2020 | Dec 31, 2020 | $2.02B | +2.0% |
| FY2019 | Dec 31, 2019 | $1.98B | +5.2% |
| FY2018 | Dec 31, 2018 | $1.88B | +12.3% |
| FY2017 | Dec 31, 2017 | $1.68B | +93.8% |
| FY2016 | Dec 31, 2016 | $865.00M | +11.8% |
| FY2015 | Dec 31, 2015 | $774.00M | +8.9% |
| FY2014 | Dec 31, 2014 | $711.00M | +24.8% |
| FY2013 | Dec 31, 2013 | $569.84M | +15.2% |
| FY2012 | Dec 31, 2012 | $494.72M | +13.1% |
| FY2011 | Dec 31, 2011 | $437.26M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $893.00M | +6.4% |
| Q2 FY2026 | Jun 30, 2026 | $798.00M | +2.0% |
| Q1 FY2026 | Mar 31, 2026 | $802.00M | +5.4% |
| Q4 FY2025 | Dec 31, 2025 | $944.00M | +1.6% |
| Q3 FY2025 | Sep 30, 2025 | $839.00M | +1.3% |
| Q2 FY2025 | Jun 30, 2025 | $782.00M | -0.9% |
| Q1 FY2025 | Mar 31, 2025 | $761.00M | -1.2% |
| Q4 FY2024 | Dec 31, 2024 | $929.00M | +13.7% |
| Q3 FY2024 | Sep 30, 2024 | $828.00M | +6.4% |
| Q2 FY2024 | Jun 30, 2024 | $789.00M | +0.8% |
| Q1 FY2024 | Mar 31, 2024 | $770.00M | +6.4% |
| Q4 FY2023 | Dec 31, 2023 | $817.00M | +11.0% |
| Q3 FY2023 | Sep 30, 2023 | $778.00M | +8.1% |
| Q2 FY2023 | Jun 30, 2023 | $783.00M | +8.3% |
| Q1 FY2023 | Mar 31, 2023 | $724.00M | -3.5% |
| Q4 FY2022 | Dec 31, 2022 | $736.00M | +1.5% |
| Q3 FY2022 | Sep 30, 2022 | $720.00M | +12.9% |
| Q2 FY2022 | Jun 30, 2022 | $723.00M | +14.9% |
| Q1 FY2022 | Mar 31, 2022 | $750.00M | +12.8% |
| Q4 FY2021 | Dec 31, 2021 | $725.00M | +14.5% |
| Q3 FY2021 | Sep 30, 2021 | $638.00M | +26.1% |
| Q2 FY2021 | Jun 30, 2021 | $629.00M | +70.0% |
| Q1 FY2021 | Mar 31, 2021 | $665.00M | +30.6% |
| Q4 FY2020 | Dec 31, 2020 | $633.00M | +31.9% |
| Q3 FY2020 | Sep 30, 2020 | $506.00M | +0.6% |
| Q2 FY2020 | Jun 30, 2020 | $370.00M | -24.6% |
| Q1 FY2020 | Mar 31, 2020 | $509.00M | +0.8% |
| Q4 FY2019 | Dec 31, 2019 | $480.00M | -4.2% |
| Q3 FY2019 | Sep 30, 2019 | $503.00M | +8.4% |
| Q2 FY2019 | Jun 30, 2019 | $491.00M | +8.6% |
| Q1 FY2019 | Mar 31, 2019 | $505.00M | +8.6% |
| Q4 FY2018 | Dec 31, 2018 | $501.00M | +19.3% |
| Q3 FY2018 | Sep 30, 2018 | $464.00M | +2.9% |
| Q2 FY2018 | Jun 30, 2018 | $452.00M | +21.8% |
| Q1 FY2018 | Mar 31, 2018 | $465.00M | +7.1% |
| Q4 FY2017 | Dec 31, 2017 | $420.00M | +25.4% |
| Q3 FY2017 | Sep 30, 2017 | $451.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $371.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $434.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $335.00M | – |
See a number that looks wrong?